Latest filing published 03 Apr 2008 for ENCYSIVE PHARMACEUTICALS INC, €70k.
No signal scores available.
Suzanne Oparil appears in our data through filings on Encysive Pharmaceuticals Inc shares, published by SEC (Form 4). Over a trading history stretching from 31 December 2005 to 1 April 2008, the count stands at 10 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 3 April 2008 came the latest disclosure, a transaction for €70k in Encysive Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations